Abstract
Coronavirus disease of 2019 (COVID-19) is a relatively new pandemic; the first reported case was in late 2019, and the first vaccine was given in December 2020. To this date, multiple side effects have been reported with COVID-19 vaccines. Nonetheless, autoimmune (AI) diseases with the COVID-19 vaccine have rarely been associated. We described herein a case of sudden onset of vitiligo occurring after the first dose of the COVID-19 vaccine. To date, there are less than 10 reported cases of vitiligo post-COVID-19 vaccine. This report aims to recognize AI disease presentation with vaccines, specifically COVID-19.
Cite
CITATION STYLE
Alnaim, A. A., Al-Mulhim, A. N., Al-Momen, M. M., & Shaikh, L. Y. (2022). Saudi Adolescent Present with New-Onset Vitiligo Post-COVID-19 Vaccination: Case Report. Journal of Dermatology and Dermatologic Surgery, 26(2), 96–98. https://doi.org/10.4103/jdds.jdds_35_22
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.